Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasmaWestley, I.; Sallustio, B.; Morris, R.
2007Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaInglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.
2005Evaluation of the immunotech cyclosporine direct radioimmunoassay for the determination of whole-blood cyclosporine in renal transplant patientsWesley, I.; Sallustio, B.; Morris, R.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2002Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state doseSallustio, B.; Westley, I.; Morris, R.
2004Determination of perhexiline and hydroxyperhexiline in plasma by liquid chromatography-mass spectrometryBeck, O.; Stephanson, N.; Morris, R.; Sallustio, B.; Hjemdahl, P.
2008Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR- rat liver microsomesWestley, I.; Morris, R.; Evans, A.; Sallustio, B.
2006Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: Effect of cyclosporineWestley, I.; Brogan, L.; Morris, R.; Evans, A.; Sallustio, B.